Application of Nanotechnology in TACE Treatment of Liver Cancer
Linmei Yao,1,* Zixuan Gao,1,* Xin Wei,1,* Shuojie Wang,1,* Weihua Cao,1 Wen Deng,1 Xinxin Li,1 Ziyu Zhang,1 Shiyu Wang,1 Yaqin Zhang,1 Ruyu Liu,1– 3 Yao Xie,1,2 Minghui Li1,2 1Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical...
Saved in:
| Main Authors: | Yao L, Gao Z, Wei X, Wang S, Cao W, Deng W, Li X, Zhang Z, Zhang Y, Liu R, Xie Y, Li M |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-08-01
|
| Series: | International Journal of Nanomedicine |
| Subjects: | |
| Online Access: | https://www.dovepress.com/application-of-nanotechnology-in-tace-treatment-of-liver-cancer-peer-reviewed-fulltext-article-IJN |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Development and Validation of a Radiomics Nomogram Based on Magnetic Resonance Imaging and Clinicoradiological Factors to Predict HCC TACE Refractoriness
by: Dong Y, et al.
Published: (2025-07-01) -
Development of a Nomogram for Prognostic Prediction of Large Hepatocellular Carcinoma With HBV After TACE Combined Conversion Therapy
by: Xu W, et al.
Published: (2025-04-01) -
Prognostic impact of tace combined with sorafenib or lenvatinib followed by regorafenib in recurrent hepatocellular carcinoma after liver transplantation: a retrospective study
by: Zhao-dan Ye, et al.
Published: (2025-07-01) -
Efficacy Analysis of TACE Combined with Lenvatinib and PD-1 Inhibitors in the Treatment of Hepatitis B Virus-Related Unresectable Hepatocellular Carcinoma
by: Yu J, et al.
Published: (2025-07-01) -
Survival in patients with unresectable hepatocellular carcinoma: TCC cocktail plus TACE vs TACE alone prospective randomized clinical trial
by: Jie Li, et al.
Published: (2025-07-01)